标题
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
作者
关键词
Direct-Acting Antiviral, Fibrosis Regression, Hepatitis C Virus, Sustained Virologic Response
出版物
GASTROENTEROLOGY
Volume 160, Issue 5, Pages 1502-1520.e1
出版商
Elsevier BV
发表日期
2021-01-30
DOI
10.1053/j.gastro.2020.09.065
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of Lineage-specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
- (2020) Xiao Liu et al. GASTROENTEROLOGY
- High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C
- (2020) Naoki Kawagishi et al. HEPATOLOGY RESEARCH
- Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis
- (2020) Ida Falk Villesen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Why do so many NASH trials fail?
- (2020) Vlad Ratziu et al. GASTROENTEROLOGY
- 1006 PREDICTORS OF POOR FIBROSIS REGRESSION AFTER DIRECT ACTING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS
- (2020) Shaurya Prakash et al. GASTROENTEROLOGY
- Hepatic fibrosis: A convergent response to liver injury that is reversible
- (2020) Shuang Wang et al. JOURNAL OF HEPATOLOGY
- Senolytic CAR T cells reverse senescence-associated pathologies
- (2020) Corina Amor et al. NATURE
- Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C
- (2020) Yamini Kalidindi et al. JAMA Network Open
- Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
- (2019) Uchenna Agbim et al. Expert Review of Gastroenterology & Hepatology
- AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis
- (2019) Anissa A. Widjaja et al. GASTROENTEROLOGY
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN ‐free therapy
- (2019) Mattias Mandorfer et al. HEPATOLOGY
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- A novel deactivation factor of fibrogenic hepatic stellate cells induces regression of liver fibrosis in mice
- (2019) Yasuhiro Nakano et al. HEPATOLOGY
- Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations
- (2019) Carmine Rossi et al. JOURNAL OF HEPATOLOGY
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding
- (2019) Andrew M. Moon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy
- (2019) Rui Huang et al. DIGESTIVE DISEASES AND SCIENCES
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- Safety profile of autologous macrophage therapy for liver cirrhosis
- (2019) Francesca Moroni et al. NATURE MEDICINE
- Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
- (2019) Ross Dobie et al. Cell Reports
- Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
- (2019) Daphne van der Heide et al. Frontiers in Immunology
- Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts
- (2018) Loretta L Jophlin et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis
- (2018) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis
- (2018) Lucas A. Hill et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
- (2018) Vincenza Calvaruso et al. GASTROENTEROLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C
- (2018) Ezequiel Mauro et al. HEPATOLOGY
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eradication of hepatitis C virus in patients with decompensated cirrhosis does not improve the management of ascites after one year of follow-up
- (2018) A. Juanola et al. JOURNAL OF HEPATOLOGY
- The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen
- (2018) Hamish Innes et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
- (2018) Antonietta Romano et al. JOURNAL OF HEPATOLOGY
- Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample
- (2018) Mona Haj et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States
- (2018) Allison Kwong et al. LIVER TRANSPLANTATION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Assessment of Liver Fibrosis Progression and Regression by a Serological Collagen Turnover Profile
- (2018) Morten Asser Karsdal et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Reversibility of Schistosomal Periportal Thickening/Fibrosis after Praziquantel Therapy: A Twenty-Six Month Follow-up Study in Ethiopia
- (2018) Nega Berhe et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
- (2018) George N. Ioannou et al. GASTROENTEROLOGY
- Wnt–β-catenin signalling in liver development, health and disease
- (2018) Maria J. Perugorria et al. Nature Reviews Gastroenterology & Hepatology
- American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis
- (2017) Joseph K. Lim et al. GASTROENTEROLOGY
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
- (2017) Sabela Lens et al. GASTROENTEROLOGY
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
- (2017) Pierre Nahon et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
- (2017) Siddharth Singh et al. GASTROENTEROLOGY
- Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature
- (2017) Atsushi Ono et al. HEPATOLOGY
- Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort
- (2017) Dana J.T. Bruden et al. HEPATOLOGY
- Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
- (2017) Adriaan J. van der Meer et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
- (2017) R. Bielen et al. JOURNAL OF VIRAL HEPATITIS
- Upregulation of the actin cytoskeleton via myocardin leads to increased expression of type 1 collagen
- (2017) Zengdun Shi et al. LABORATORY INVESTIGATION
- IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
- (2017) Mohammed Eslam et al. NATURE GENETICS
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes
- (2017) Li Bai et al. Scientific Reports
- Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
- (2016) Cynthia Ju et al. Cellular & Molecular Immunology
- Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection
- (2016) Mei Lu et al. Clinical Gastroenterology and Hepatology
- Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
- (2016) Vito Di Marco et al. GASTROENTEROLOGY
- Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy
- (2016) Jennifer A. Flemming et al. HEPATOLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
- (2016) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
- (2016) Mattias Mandorfer et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
- (2016) Savino Bruno et al. JOURNAL OF HEPATOLOGY
- Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
- (2016) V. Knop et al. JOURNAL OF VIRAL HEPATITIS
- Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis
- (2016) Silvia Martini et al. LIVER INTERNATIONAL
- Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index
- (2016) Jacqueline A. Bachofner et al. LIVER INTERNATIONAL
- Liver regeneration — mechanisms and models to clinical application
- (2016) Stuart J. Forbes et al. Nature Reviews Gastroenterology & Hepatology
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
- (2015) Morten A. Karsdal et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response
- (2015) José Luis Casado et al. DIGESTIVE DISEASES AND SCIENCES
- Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
- (2015) C. Mogler et al. EMBO Molecular Medicine
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Resetting the transcription factor network reverses terminal chronic hepatic failure
- (2015) Taichiro Nishikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of fibrosis progression on clinical outcome in patients treated for post- transplant hepatitis C recurrence
- (2015) Renumathy Dhanasekaran et al. LIVER INTERNATIONAL
- Fibrosis — A Common Pathway to Organ Injury and Failure
- (2015) Don C. Rockey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resolution of Liver Fibrosis: Basic Mechanisms and Clinical Relevance
- (2015) Prakash Ramachandran et al. SEMINARS IN LIVER DISEASE
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Systematic review: the effects of autologous stem cell therapy for patients with liver disease
- (2014) J. K. Moore et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
- (2014) Youngmin A. Lee et al. ANTIVIRAL RESEARCH
- Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming
- (2014) Atsushi Miyajima et al. Cell Stem Cell
- Identifying Molecular Factors That Contribute to Resolution of Liver Fibrosis
- (2014) John P. Iredale et al. GASTROENTEROLOGY
- Impact of common risk factors of fibrosis progression in chronic hepatitis C
- (2014) S Rüeger et al. GUT
- KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
- (2014) Giusi Marrone et al. GUT
- Activated Hepatic Stellate Cells Are Dependent on Self-collagen, Cleaved by Membrane Type 1 Matrix Metalloproteinase for Their Growth
- (2014) Naoko Kubo Birukawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C
- (2013) Vincent Mallet et al. ANNALS OF INTERNAL MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
- (2013) Don C. Rockey Clinical Gastroenterology and Hepatology
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
- (2013) Yun-Fan Liaw JOURNAL OF HEPATOLOGY
- Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: Meta-analysis of clinical studies
- (2013) Fabrizio Fabrizi et al. JOURNAL OF MEDICAL VIROLOGY
- Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
- (2013) Bi-Sen Ding et al. NATURE
- Measuring the Global Burden of Disease
- (2013) Christopher J.L. Murray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- Course of Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients Depending on the Response to Hepatitis C Therapy
- (2012) José-Antonio Cartón et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Autophagy fuels tissue fibrogenesis
- (2012) Virginia Hernández-Gea et al. Autophagy
- Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
- (2012) John P. Iredale et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
- (2012) Virginia Hernández–Gea et al. GASTROENTEROLOGY
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
- (2012) Juliane S. Troeger et al. GASTROENTEROLOGY
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
- (2012) Xiaoni Kong et al. HEPATOLOGY
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
- (2012) T. Kisseleva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
- (2012) P. Ramachandran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
- (2011) Abby L. Olsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
- (2011) Joy X. Jiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice
- (2011) Yury Popov et al. GASTROENTEROLOGY
- A role for autophagy during hepatic stellate cell activation
- (2011) Lien F.R. Thoen et al. JOURNAL OF HEPATOLOGY
- Renal failure and cirrhosis: A systematic review of mortality and prognosis
- (2011) Giuseppe Fede et al. JOURNAL OF HEPATOLOGY
- PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis
- (2010) J.S. Duffield et al. DRUG NEWS & PERSPECTIVES
- Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
- (2010) Vasiliki Arvaniti et al. GASTROENTEROLOGY
- Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study
- (2010) Savino Bruno et al. HEPATOLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Evolution of the Pentraxin Family: The New Entry PTX4
- (2010) Y. Martinez de la Torre et al. JOURNAL OF IMMUNOLOGY
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
- (2009) John McHutchison et al. GASTROENTEROLOGY
- Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
- (2009) Zachary D. Goodman et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- Serum Amyloid P Inhibits Fibrosis Through Fc R-Dependent Monocyte-Macrophage Regulation in Vivo
- (2009) A. P. Castano et al. Science Translational Medicine
- Senescence of Activated Stellate Cells Limits Liver Fibrosis
- (2008) Valery Krizhanovsky et al. CELL
- Partial Hepatectomy–Induced Regeneration Accelerates Reversion of Liver Fibrosis Involving Participation of Hepatic Stellate Cells
- (2008) Juan A. Suárez-Cuenca et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
- (2008) Don C. Rockey GASTROENTEROLOGY
- Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
- (2008) Sarah Maylin et al. GASTROENTEROLOGY
- Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
- (2008) Laurie D. DeLeve et al. HEPATOLOGY
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started